Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshiro K. Ohsumi is active.

Publication


Featured researches published by Toshiro K. Ohsumi.


Nature Neuroscience | 2013

The microglial sensome revealed by direct RNA sequencing

Suzanne E. Hickman; Nathan D. Kingery; Toshiro K. Ohsumi; Mark L. Borowsky; Li-chong Wang; Terry K. Means; Joseph El Khoury

Microglia, the principal neuroimmune sentinels of the brain, continuously sense changes in their environment and respond to invading pathogens, toxins and cellular debris. Microglia exhibit plasticity and can assume neurotoxic or neuroprotective priming states that determine their responses to danger. We used direct RNA sequencing, without amplification or cDNA synthesis, to determine the quantitative transcriptomes of microglia of healthy adult and aged mice. We validated our findings using fluorescence dual in situ hybridization, unbiased proteomic analysis and quantitative PCR. We found that microglia have a distinct transcriptomic signature and express a unique cluster of transcripts encoding proteins for sensing endogenous ligands and microbes that we refer to as the sensome. With aging, sensome transcripts for endogenous ligand recognition were downregulated, whereas those involved in microbe recognition and host defense were upregulated. In addition, aging was associated with an overall increase in the expression of microglial genes involved in neuroprotection.


American Journal of Human Genetics | 2011

Next-Generation Sequencing Strategies Enable Routine Detection of Balanced Chromosome Rearrangements for Clinical Diagnostics and Genetic Research

Michael E. Talkowski; Carl Ernst; Adrian Heilbut; Colby Chiang; Carrie Hanscom; Amelia M. Lindgren; Andrew Kirby; Shangtao Liu; Bhavana Muddukrishna; Toshiro K. Ohsumi; Yiping Shen; Mark L. Borowsky; Mark J. Daly; Cynthia C. Morton; James F. Gusella

The contribution of balanced chromosomal rearrangements to complex disorders remains unclear because they are not detected routinely by genome-wide microarrays and clinical localization is imprecise. Failure to consider these events bypasses a potentially powerful complement to single nucleotide polymorphism and copy-number association approaches to complex disorders, where much of the heritability remains unexplained. To capitalize on this genetic resource, we have applied optimized sequencing and analysis strategies to test whether these potentially high-impact variants can be mapped at reasonable cost and throughput. By using a whole-genome multiplexing strategy, rearrangement breakpoints could be delineated at a fraction of the cost of standard sequencing. For rearrangements already mapped regionally by karyotyping and fluorescence in situ hybridization, a targeted approach enabled capture and sequencing of multiple breakpoints simultaneously. Importantly, this strategy permitted capture and unique alignment of up to 97% of repeat-masked sequences in the targeted regions. Genome-wide analyses estimate that only 3.7% of bases should be routinely omitted from genomic DNA capture experiments. Illustrating the power of these approaches, the rearrangement breakpoints were rapidly defined to base pair resolution and revealed unexpected sequence complexity, such as co-occurrence of inversion and translocation as an underlying feature of karyotypically balanced alterations. These findings have implications ranging from genome annotation to de novo assemblies and could enable sequencing screens for structural variations at a cost comparable to that of microarrays in standard clinical practice.


The Journal of Infectious Diseases | 2016

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

Sahil Khanna; Darrell S. Pardi; Colleen R. Kelly; Colleen S. Kraft; Tanvi Dhere; Matthew R. Henn; Mary Jane Lombardo; Marin Vulic; Toshiro K. Ohsumi; Jonathan Winkler; Christina Pindar; Barbara H. McGovern; Roger J. Pomerantz; John Grant Aunins; David N. Cook; Elizabeth L. Hohmann

BACKGROUND Patients with recurrent Clostridium difficile infection (CDI) have a ≥60% risk of relapse, as conventional therapies do not address the underlying gastrointestinal dysbiosis. This exploratory study evaluated the safety and efficacy of bacterial spores for preventing recurrent CDI. METHODS Stool specimens from healthy donors were treated with ethanol to eliminate pathogens. The resulting spores were fractionated and encapsulated for oral delivery as SER-109. Following their response to standard-of-care antibiotics, patients in cohort 1 were treated with SER-109 on 2 consecutive days (geometric mean dose, 1.7 × 10(9) spores), and those in cohort 2 were treated on 1 day (geometric mean dose, 1.1 × 10(8) spores). The primary efficacy end point was absence of C. difficile-positive diarrhea during an 8-week follow-up period. Microbiome alterations were assessed. RESULTS Thirty patients (median age, 66.5 years; 67% female) were enrolled, and 26 (86.7%) met the primary efficacy end point. Three patients with early, self-limiting C. difficile-positive diarrhea did not require antibiotics and tested negative for C. difficile at 8 weeks; thus, 96.7% (29 of 30) achieved clinical resolution. In parallel, gut microbiota rapidly diversified, with durable engraftment of spores and no outgrowth of non-spore-forming bacteria found after SER-109 treatment. Adverse events included mild diarrhea, abdominal pain, and nausea. CONCLUSIONS SER-109 successfully prevented CDI and had a favorable safety profile, supporting a novel microbiome-based intervention as a potential therapy for recurrent CDI.


The EMBO Journal | 2009

Systematic and single-cell analysis of Xenopus Piwi-interacting RNAs and Xiwi.

Nelson C. Lau; Toshiro K. Ohsumi; Mark L. Borowsky; Robert E. Kingston; Michael D. Blower

Piwi proteins and Piwi‐interacting RNAs (piRNAs) are essential for germ cell development, but analysis of the molecular mechanisms of these ribonucleoproteins remains challenging in most animal germ cells. To address this challenge, we systematically characterized Xiwi, a Xenopus Piwi homologue, and piRNAs from Xenopus eggs and oocytes. We used the large size of Xenopus eggs to analyze small RNAs at the single cell level, and find abundant piRNAs and large piRNA clusters in the Xenopus tropicalis genome, some of which resemble the Drosophila piRNA‐generating flamenco locus. Although most piRNA clusters are expressed simultaneously in an egg, individual frogs show distinct profiles of cluster expression. Xiwi is associated with microtubules and the meiotic spindle, and is localized to the germ plasm—a cytoplasmic determinant of germ cell formation. Xiwi associates with translational regulators in an RNA‐dependent manner, but Xenopus tudor interacts with Xiwi independently of RNA. Our study adds insight to piRNA transcription regulation by showing that individual animals can have differential piRNA expression profiles. We suggest that in addition to regulating transposable elements, Xiwi may function in specifying RNA localization in vertebrate oocytes.


Nature Methods | 2009

Sensitive, Specific Polymorphism Discovery in Bacteria Using Massively Parallel Sequencing

Chad Nusbaum; Toshiro K. Ohsumi; James Gomez; John Aquadro; Thomas C. Victor; Robert M. Warren; Deborah T. Hung; Bruce Birren; Eric S. Lander; David B. Jaffe

Our variant ascertainment algorithm, VAAL, uses massively parallel DNA sequence data to identify differences between bacterial genomes with high sensitivity and specificity. VAAL detected ∼98% of differences (including large insertion-deletions) between pairs of strains from three species while calling no false positives. VAAL also pinpointed a single mutation between Vibrio cholerae genomes, identifying an antibiotics site of action by identifying sequence differences between drug-sensitive strains and drug-resistant derivatives.


The American Naturalist | 2002

Stage‐Structured Infection Transmission and a Spatial Epidemic: A Model for Lyme Disease

Thomas Caraco; Stephan Glavanakov; Gang Chen; Joseph E. Flaherty; Toshiro K. Ohsumi; Boleslaw K. Szymanski

A greater understanding of the rate at which emerging disease advances spatially has both ecological and applied significance. Analyzing the spread of vector‐borne disease can be relatively complex when the vectors acquisition of a pathogen and subsequent transmission to a host occur in different life stages. A contemporary example is Lyme disease. A long‐lived tick vector acquires infection during the larval blood meal and transmits it as a nymph. We present a reaction‐diffusion model for the ecological dynamics governing the velocity of the current epidemics spread. We find that the equilibrium density of infectious tick nymphs (hence the risk of human disease) can depend on density‐independent survival interacting with biotic effects on the tick’s stage structure. The local risk of infection reaches a maximum at an intermediate level of adult tick mortality and at an intermediate rate of juvenile tick attacks on mammalian hosts. If the juvenile tick attack rate is low, an increase generates both a greater density of infectious nymphs and an increased spatial velocity. However, if the juvenile attack rate is relatively high, nymph density may decline while the epidemic’s velocity still increases. Velocities of simulated two‐dimensional epidemics correlate with the model pathogen’s basic reproductive number ( \documentclass{aastex} \usepackage{amsbsy} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{bm} \usepackage{mathrsfs} \usepackage{pifont} \usepackage{stmaryrd} \usepackage{textcomp} \usepackage{portland,xspace} \usepackage{amsmath,amsxtra} \usepackage[OT2,OT1]{fontenc} \newcommand\cyr{ \renewcommand\rmdefault{wncyr} \renewcommand\sfdefault{wncyss} \renewcommand\encodingdefault{OT2} \normalfont \selectfont} \DeclareTextFontCommand{\textcyr}{\cyr} \pagestyle{empty} \DeclareMathSizes{10}{9}{7}{6} \begin{document} \landscape


Current Opinion in Allergy and Clinical Immunology | 2012

Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.

Janet Chou; Toshiro K. Ohsumi; Raif S. Geha


Molecular Biology of the Cell | 2011

Functional analysis of the microtubule-interacting transcriptome

Judith A. Sharp; Joshua J. Plant; Toshiro K. Ohsumi; Mark L. Borowsky; Michael D. Blower

R_{0}


Nature Genetics | 2016

A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency

Haifa H. Jabara; Steven E. Boyden; Janet Chou; Narayanaswamy Ramesh; Michel J. Massaad; Halli Benson; Wayne Bainter; David Fraulino; Fedik Rahimov; Colin A. Sieff; Zhi-Jian Liu; Salem H. Alshemmari; Basel K. al-Ramadi; Hasan Al-Dhekri; Rand Arnaout; Mohammad Abu-Shukair; Anant Vatsayan; Eli Silver; Sanjay Ahuja; E. Graham Davies; Martha Sola-Visner; Toshiro K. Ohsumi; Nancy C. Andrews; Luigi D. Notarangelo; Mark D. Fleming; Waleed Al-Herz; Louis M. Kunkel; Raif S. Geha


BMC Cancer | 2013

Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics

Li Chen; Lynda M. Stuart; Toshiro K. Ohsumi; Shawn M. Burgess; Gaurav K. Varshney; Anahita Dastur; Mark L. Borowsky; Cyril H. Benes; Adam Lacy-Hulbert; Emmett V. Schmidt

\end{document} ), but calculating \documentclass{aastex} \usepackage{amsbsy} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{bm} \usepackage{mathrsfs} \usepackage{pifont} \usepackage{stmaryrd} \usepackage{textcomp} \usepackage{portland,xspace} \usepackage{amsmath,amsxtra} \usepackage[OT2,OT1]{fontenc} \newcommand\cyr{ \renewcommand\rmdefault{wncyr} \renewcommand\sfdefault{wncyss} \renewcommand\encodingdefault{OT2} \normalfont \selectfont} \DeclareTextFontCommand{\textcyr}{\cyr} \pagestyle{empty} \DeclareMathSizes{10}{9}{7}{6} \begin{document} \landscape

Collaboration


Dive into the Toshiro K. Ohsumi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Janet Chou

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Raif S. Geha

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph E. Flaherty

Rensselaer Polytechnic Institute

View shared research outputs
Top Co-Authors

Avatar

David N. Cook

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wayne Bainter

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge